These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4959020)

  • 1. Studies on the isolation of an infection-protective antigen from Psudomonas aeruginosa.
    Alexander JW; Brown W; Walker H; Mason AD; Moncrief JA
    Surg Gynecol Obstet; 1966 Nov; 123(5):965-77. PubMed ID: 4959020
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
    Jones RJ
    Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
    Sokalska M; Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies].
    Ye DN; Wang CX; Yan RH; Dai BM; Ni HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of generalization of wound infection in immunized rats].
    Pal'tsyn AA; Grishina IA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Popova EP
    Biull Eksp Biol Med; 1994 May; 117(5):545-6. PubMed ID: 9296716
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriopyncnosis--morphological expression of bacterial death in an animal].
    Pal'tsyn AA; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Grishina IA; Popova EP
    Biull Eksp Biol Med; 1995 Jun; 119(6):665-8. PubMed ID: 8589403
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
    Döring G; Dorner F
    Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
    Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infections in minks caused by Pseudomonas aeruginosa. Infection and vaccination trials].
    Karlsson KA; Kull KE; Svanholm R
    Nord Vet Med; 1971; 23(7):345-51. PubMed ID: 5004400
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of hyperimmune anti-Pseudomonas plasma in the treatment of infectious complications].
    Grishina IA; Terekhova RP; Marchuk AI; Elagina LV; Ostrovskaia EV; Nezhlukto AIa
    Khirurgiia (Mosk); 1990 Nov; (11):121-3. PubMed ID: 2127294
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of antibodies to microorganisms in a focus of purulent inflammation].
    Pal'tsyn AA; Kolokol'chikova EG; Grishina IA; Chervonskaia NV; Badikova AK; Popova EP
    Arkh Patol; 1994; 56(5):15-9. PubMed ID: 7695487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological studies of pseudomonas hospitalism (author's transl)].
    May W; Burchardi H; Killian W
    MMW Munch Med Wochenschr; 1974 Jan; 116(3):97-104. PubMed ID: 4205625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
    Zarubina EK; Svetukhin AM; Edvabnaia LS
    Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reduced phagocytosis in immunized animals].
    Pal'tsyn AA; Kolokol'chikova EG; Badikova AK; Chervonskaia NV; Grishina IA
    Biull Eksp Biol Med; 1996 Sep; 122(9):348-52. PubMed ID: 8974498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.